Home › Therapeutic areas › Oncology › Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma (5 companies)

Companies with an active program in Diffuse Large B-Cell Lymphoma.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ADCT ADC Therapeutics Oncology 1 Approved $172M 5
AUTL Autolus Therapeutics HematologyImmunology+3 Rare 1 Approved $290M 12
CLRB Cellectar Biosciences Oncology 1 Phase 2 $9.2M 7
FHTX Foghorn Therapeutics Oncology 1 Preclinical $110M 4
XNCR Xencor ImmunologyNeurology+1 Rare 1 Approved $2.59B 28